Login / Signup

New Pyrimidinone-Fused 1,4-Naphthoquinone Derivatives Inhibit the Growth of Drug Resistant Oral Bacteria.

Kyungmin KimDaseul KimHyunjin LeeTae Hoon LeeKi-Young KimHakwon Kim
Published in: Biomedicines (2020)
Pyrimidinone-fused 1,4-naphthoquinones synthesized from simple starting compounds and four known 1,4-naphthoquinones were synthesized and showed strong antibacterial activity to the 9 common oral bacteria. These results suggest that these derivatives should be prospective for the treatment of dental diseases caused by oral bacteria, including drug-resistant strains.
Keyphrases
  • drug resistant
  • multidrug resistant
  • acinetobacter baumannii
  • cystic fibrosis
  • oral health
  • oxide nanoparticles
  • replacement therapy
  • silver nanoparticles